All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @kmartfit on TikTok · 23s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @kmartfit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00How many milligrams of testosterone am I on per week?
  2. 0:02I've been on Dr. Prescribed TRT for over three years
  3. 0:04and I currently take 180 milligrams per week.
  4. 0:07I split that dosage up into two separate injections
  5. 0:09for a more stable blood level.
  6. 0:10My total testosterone levels hover right around 950
  7. 0:13to 1,000 and I feel freaking amazing.
  8. 0:15So if you're looking into starting TRT,
  9. 0:17I wanna connect you with the right resources
  10. 0:18that are online to begin your journey.
  11. 0:20Comment the word TRT down in the comments below
  12. 0:21and I'll send you off some information.

@kmartfit's TRT dosing claims need more context

KMART

TikTok creator

7.9K viewsWatch on TikTok

Quick answer

The creator discloses a personal TRT protocol of 180mg testosterone per week split into two injections, reporting total testosterone levels of 950-1,000 ng/dL. This sits at the upper boundary of the AUA's clinical target range and is above the median dose used in most TRT trials, though individual pharmacokinetics vary considerably. The content lacks any reference to lab monitoring, hematocrit tracking, or cardiovascular screening, which are standard components of ongoing TRT management.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @kmartfit's TRT dosing claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@kmartfit's TRT dosing claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@kmartfit's TRT dosing claims need more context" from KMART. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator discloses a personal TRT protocol of 180mg testosterone per week split into two injections, reporting total testosterone levels of 950-1,000 ng/dL.

The reason this review is not generic is the source wording and the canonical claim label "trt my dose of trt." In this clip, the useful excerpt is: "How many milligrams of testosterone am I on per week?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Twice-weekly injection of testosterone cypionate or enanthate is evidence-supported for reducing serum level fluctuation, per Ramasamy et al.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator discloses a personal TRT protocol of 180mg testosterone per week split into two injections, reporting total testosterone levels of 950-1,000 ng/dL.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator discloses a personal TRT protocol of 180mg testosterone per week split into two injections, reporting total testosterone levels of 950-1,000 ng/dL. This sits at the upper boundary of the AUA's clinical target range and is above the median dose used in most TRT trials, though individual pharmacokinetics vary considerably. The content lacks any reference to lab monitoring, hematocrit tracking, or cardiovascular screening, which are standard components of ongoing TRT management.
  • AUA 2018 guidelines target 400-700 ng/dL for most TRT patients; 950-1,000 ng/dL is at the upper boundary of clinical acceptability, not the typical goal
  • Twice-weekly injection of testosterone cypionate or enanthate is evidence-supported for reducing serum level fluctuation, per Ramasamy et al. (2020, Urology)

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • AUA 2018 guidelines target 400-700 ng/dL for most TRT patients; 950-1,000 ng/dL is at the upper boundary of clinical acceptability, not the typical goal
  • Twice-weekly injection of testosterone cypionate or enanthate is evidence-supported for reducing serum level fluctuation, per Ramasamy et al. (2020, Urology)
  • 180mg per week is above the commonly studied replacement dose range of 75-100mg per week; individual response varies enough that this dose could produce very different results in another person
  • The 2023 TRAVERSE trial (New England Journal of Medicine) found no significant increase in major cardiovascular events on TRT versus placebo over 33 months, but this was in a specific patient population with cardiovascular risk factors, not a blanket safety endorsement
  • Erythrocytosis is the most common adverse effect of injectable testosterone therapy; hematocrit should be monitored every 3-6 months, a fact absent from this content
  • Clinically diagnosed hypogonadism requires total testosterone below approximately 300 ng/dL plus symptoms; TRT is not indicated solely for optimization in men with normal baseline levels
  • Any online TRT service that does not require baseline labs including total testosterone, LH, FSH, hematocrit, PSA, and a lipid panel before prescribing is not following standard clinical practice

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @kmartfit actually say?

He's been on doctor-prescribed TRT for over three years, takes 180mg of testosterone per week, splits it into two injections for blood level stability, and says his total testosterone runs between 950 and 1,000 ng/dL. He feels "freaking amazing" and is pointing followers toward online TRT resources via a comment-funnel. That's the full picture. No product names, no injection instructions, just a personal protocol disclosure and a lead-gen hook.

Does the science back this up?

Partially. The split-dosing rationale is solid. The testosterone level he's targeting sits at the high end of what most clinicians would consider acceptable, but it's not outside the range of published practice.

Splitting a weekly testosterone cypionate or enanthate dose into two injections does reduce peak-to-trough fluctuation. A 2020 study by Ramasamy et al. in Urology confirmed that more frequent dosing intervals correlate with more stable serum levels and fewer side effects tied to supraphysiologic peaks. That part checks out.

The 950-1,000 ng/dL target is trickier. The American Urological Association's 2018 guidelines set the target range for TRT at roughly 400-700 ng/dL for most men, with some clinicians accepting up to 1,000 ng/dL. His stated levels sit at the ceiling of that range, not the center. That's not automatically dangerous, but it's worth flagging.

What did they get wrong (or right)?

Let's give credit where it's due: split dosing is genuinely better than once-weekly injections for stability, and he's being transparent about his numbers rather than vague-posting. That's more than most TRT content on this platform offers.

What's missing is context about why 180mg lands him at 950-1,000 ng/dL. Testosterone response varies considerably between individuals based on SHBG levels, conversion rates, and injection site. Someone watching this who starts 180mg expecting identical results could end up at 1,400 ng/dL or 600 ng/dL. Presenting a personal dose without that disclaimer is where the content gets quietly misleading.

The comment-funnel to "online resources" is also worth scrutinizing. Directing followers to unspecified online TRT services without any mention of baseline labs, cardiovascular screening, or hematocrit monitoring is an incomplete picture of what responsible TRT initiation looks like.

What should you actually know?

Testosterone replacement therapy is a legitimate, FDA-approved treatment for clinically diagnosed hypogonadism, defined as total testosterone below roughly 300 ng/dL combined with symptoms. It is not a general wellness upgrade for men who feel tired or want more muscle.

Before anyone starts TRT, labs should include total and free testosterone, LH, FSH, hematocrit, PSA, and a lipid panel at minimum. A 2017 review by Bhasin et al. in the New England Journal of Medicine outlined that erythrocytosis (elevated red blood cell count) is one of the most common adverse effects of injectable testosterone, particularly at higher doses and less frequent intervals. Monitoring hematocrit every three to six months matters.

Cardiovascular risk remains an open debate. The 2023 TRAVERSE trial published in the New England Journal of Medicine found no significant increase in major cardiovascular events in men on TRT versus placebo over about 33 months, which was reassuring but not a blanket green light for all patients.

Is this content safe to act on?

As personal disclosure, it's mostly fine. As a blueprint for starting TRT, it has real gaps. The dose he mentions is above average for replacement therapy. His target testosterone level is at the upper boundary of clinical guidelines. And the call to action, "comment TRT and I'll send you resources," offers no context about whether those resources involve actual diagnostic workups or just telehealth prescription services that skip the hard parts.

If you're exploring TRT, the right starting point is a full hormone panel from a licensed provider, not a comment thread. What works for a 3-year veteran with established labs and physician oversight is not a template for someone who has never had their testosterone measured.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

KMART · TikTok creator

7.9K views on this video

My dose of TRT

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about aua 2018 guidelines target 400-700 ng/dl for most trt patients;?

AUA 2018 guidelines target 400-700 ng/dL for most TRT patients; 950-1,000 ng/dL is at the upper boundary of clinical acceptability, not the typical goal

What does the video say about twice-weekly injection of testosterone cypionate?

Twice-weekly injection of testosterone cypionate or enanthate is evidence-supported for reducing serum level fluctuation, per Ramasamy et al. (2020, Urology)

What does the video say about 180mg per week?

180mg per week is above the commonly studied replacement dose range of 75-100mg per week; individual response varies enough that this dose could produce very different results in another person

What does the video say about the 2023 traverse trial (new england journal of medicine) found?

The 2023 TRAVERSE trial (New England Journal of Medicine) found no significant increase in major cardiovascular events on TRT versus placebo over 33 months, but this was in a specific patient population with cardiovascular risk factors, not a blanket safety endorsement

What does the video say about erythrocytosis?

Erythrocytosis is the most common adverse effect of injectable testosterone therapy; hematocrit should be monitored every 3-6 months, a fact absent from this content

What does the video say about clinically diagnosed hypogonadism requires total testosterone below approximately 300 ng/dl?

Clinically diagnosed hypogonadism requires total testosterone below approximately 300 ng/dL plus symptoms; TRT is not indicated solely for optimization in men with normal baseline levels

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.